Page last updated: 2024-08-24

phosphoramidic acid and Malignant Melanoma

phosphoramidic acid has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Altman, S; Burakova, EA; Fokina, AA; Gaponova Miroshnichenko, SK; Gladkikh, DV; Maslov, MA; Patutina, OA; Savin, IA; Sen'kova, AV; Shmendel', EV; Stetsenko, DA; Vlassov, VV; Wood, MJA; Zenkova, MA	1

Other Studies

1 other study(ies) available for phosphoramidic acid and Malignant Melanoma

Article	Year
Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-22, Volume: 117, Issue:51 Topics: Amides; Animals; Antineoplastic Agents; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Male; Melanoma; Mice, SCID; MicroRNAs; Molecular Targeted Therapy; Oligonucleotides, Antisense; Phosphoric Acids; Tissue Distribution; Xenograft Model Antitumor Assays	2020

Article

Year

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-22, Volume: 117, Issue:51

Topics: Amides; Animals; Antineoplastic Agents; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Male; Melanoma; Mice, SCID; MicroRNAs; Molecular Targeted Therapy; Oligonucleotides, Antisense; Phosphoric Acids; Tissue Distribution; Xenograft Model Antitumor Assays

2020